Hukui Bio is a Taiwan-based company that aims to be the premier partner in the Asia-Pacific region for medtech startups and corporates. Established in November 2013, the company offers comprehensive solutions and value-added services to global medical devices customers, with a focus on medical electronics and handheld devices for digital healthcare and telemedicine. Their operations encompass designing and development in Taiwan, manufacturing in Asia, and global sales and services.
In March 2021, Hukui Bio became a member of JLabs Resource Hub and holds the distinction of being the sole CDMO service provider of MedTech Innovator in the ecosystem. The company has assembled a team of seasoned experts and investors from biomedical, tech, and financial industries, with a commitment to delivering projects on-time, on-budget, and in alignment with global quality standards. Notably, their US subsidiary, HuKui Tech (AKA HKBio), which has been fully owned by HuKui Bio since 2020, is based in the Bay area.
Having recently secured a $5.50M Series C investment from Yellowstone Holding on 12 January 2021, Hukui Bio is well-positioned to further its mission as a leading player in the medtech industry.